Operating Segments (Tables)

9 Months Ended

Sep. 30, 2021

Operating Segments

Schedule of operating segments

	Three Months Ended
	September 30,
	2021		2020
Revenues
Public Health Solutions	$	186,198	$	544,466
Specialized BioTherapeutics		—		64,345
Total	$	186,198	$	608,811
Loss from Operations
Public Health Solutions	$	(303,488)	$	(6,369)
Specialized BioTherapeutics		(1,799,898)		(643,793)
Corporate		(1,271,996)		(1,162,615)
Total	$	(3,375,382)	$	(1,812,777)
Amortization and Depreciation Expense
Public Health Solutions	$	314	$	6,651
Specialized BioTherapeutics		1,883		3,201
Corporate		6,678		7,335
Total	$	8,875	$	17,187
Other Income, Net
Specialized BioTherapeutics	$	(26,123)		22,131
Corporate		(186,046)		486
Total	$	(212,169)	$	22,617
Share-Based Compensation
Public Health Solutions	$	6,518	$	8,377
Specialized BioTherapeutics		28,506		18,962
Corporate		44,697		39,233
Total	$	79,721	$	66,572

	Nine Months Ended
	September 30,
	2021		2020
Revenues
Public Health Solutions	$	548,615	$	1,921,284
Specialized BioTherapeutics		—		117,369
Total	$	548,615	$	2,038,653
Loss from Operations
Public Health Solutions	$	(666,223)	$	(215,608)
Specialized BioTherapeutics		(4,632,872)		(9,810,296)
Corporate		(3,319,539)		(3,074,534)
Total	$	(8,618,634)	$	(13,100,438)
Amortization and Depreciation Expense
Public Health Solutions	$	941	$	21,272
Specialized BioTherapeutics		5,644		9,438
Corporate		20,029		21,925
Total	$	26,614	$	52,635
Other Income/(Loss), Net
Specialized BioTherapeutics	$	99,512	$	90,838
Corporate		(192,717)		24,450
Total	$	(93,205)	$	115,288
Share-Based Compensation
Public Health Solutions	$	20,002	$	26,219
Specialized BioTherapeutics		86,816		63,213
Corporate		148,329		121,834
Total	$	255,147	$	211,266

	As of		As of
	September 30,		December 31,
	2021		2020
Identifiable Assets
Public Health Solutions	$	48,885	$	176,447
Specialized BioTherapeutics		72,483		147,784
Corporate		29,596,430		19,567,004
Total	$	29,717,798	$	19,891,235